Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „approved“
Suchtreffer
Begriffe & Kennungen
Comirnaty · 4.8 · Initially approved Comirnaty vaccine Infants 6 to 23 months of age – after 3 doses of the 3 mcg primary series
Eintrag öffnenDegevma · 4.8 · Overall safety profile is consistent in all approved indications for Degevma.
Eintrag öffnenDupixent · 4.8 · 13 Less than 1 % of patients who received dupilumab at approved dosing regimens exhibited high titer ADA respo
Eintrag öffnenDupixent · 4.8 · Less than 1 % of patients who received dupilumab at approved dosing regimens exhibited high titer ADA response
Eintrag öffnenItuxredi · 4.8 · The overall safety profile was consistent with the well-established safety profile for rituximab in approved a
Eintrag öffnenItuxredi · 4.8 · The safety profile of rituximab in PV was consistent with the established safety profile in other approved aut
Eintrag öffnenKeppra · 4.8 · The adverse reaction profile of levetiracetam is generally similar across age groups and across the approved e
Eintrag öffnenKeppra · 4.8 · The adverse reaction profile of levetiracetam is generally similar across age groups and across the approved e
Eintrag öffnenKeppra · 4.8 · The adverse reaction profile of levetiracetam is generally similar across age groups and across the approved e
Eintrag öffnenKeppra · 4.8 · The adverse reaction profile of levetiracetam is generally similar across age groups and across the approved e
Eintrag öffnenLevetiracetam Accord · 4.8 · The adverse reaction profile of levetiracetam is generally similar across age groups and across the approved e
Eintrag öffnenLevetiracetam Actavis Group · 4.8 · The adverse reaction profile of levetiracetam is generally similar across age groups and across the approved e
Eintrag öffnenLevetiracetam Actavis · 4.8 · The adverse reaction profile of levetiracetam is generally similar across age groups and across the approved e
Eintrag öffnenLevetiracetam Hospira · 4.8 · The adverse reaction profile of levetiracetam is generally similar across age groups and across the approved e
Eintrag öffnenLevetiracetam Sun · 4.8 · The adverse reaction profile of levetiracetam is generally similar across age groups and across the approved e
Eintrag öffnenLevetiracetam Teva · 4.8 · The adverse reaction profile of levetiracetam is generally similar across age groups and across the approved e
Eintrag öffnenLevetiracetam ratiopharm · 4.8 · The adverse reaction profile of levetiracetam is generally similar across age groups and across the approved e
Eintrag öffnenLevetiracetam ratiopharm · 4.8 · The adverse reaction profile of levetiracetam is generally similar across age groups and across the approved e
Eintrag öffnenMabThera · 4.8 · 18 MabThera-exposed patients with pre-existing Kaposi’s sarcoma. These cases occurred in non-approved indicati
Eintrag öffnenMabThera · 4.8 · The overall safety profile was consistent with the well-established safety profile for MabThera in approved au
Eintrag öffnen